Collateral Sensitivity of Parthenolide via NF- κB and HIF-α Inhibition and Epigenetic Changes in Drug-Resistant Cancer Cell Lines
In conclusion, the profound cytotoxic activity of PT against various cancer cell lines particularly against BCRP-overexpressing tumor cells suggesting PT as novel candidate compound for cancer treatment.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Colon Cancer | Colorectal Cancer | Drugs & Pharmacology | Feverfew | Genetics | Multidrug Resistance | Study